These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1936061)

  • 1. Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.
    Nahata MC; Durrell DE; Ginn-Pease ME; King DR
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):49-52. PubMed ID: 1936061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?
    Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.
    Lagneau F; Marty J; Beyne P; Tod M
    J Pharmacokinet Pharmacodyn; 2005 Feb; 32(1):1-32. PubMed ID: 16175313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug.
    Stitely M; Sweet M; Slain D; Alons L; Holls W; Hochberg C; Briggs F
    Surg Infect (Larchmt); 2013 Oct; 14(5):455-9. PubMed ID: 23859672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
    Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.
    Douglas A; Udy AA; Wallis SC; Jarrett P; Stuart J; Lassig-Smith M; Deans R; Roberts MS; Taraporewalla K; Jenkins J; Medley G; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5238-42. PubMed ID: 21859939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.
    Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF
    Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefazolin dosing for surgical prophylaxis in morbidly obese patients.
    Ho VP; Nicolau DP; Dakin GF; Pomp A; Rich BS; Towe CW; Barie PS
    Surg Infect (Larchmt); 2012 Feb; 13(1):33-7. PubMed ID: 22316145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.
    Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA
    Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin pharmacokinetics in cats under surgical conditions.
    Albarellos GA; Montoya L; Passini SM; Lupi MP; Lorenzini PM; Landoni MF
    J Feline Med Surg; 2017 Oct; 19(10):992-997. PubMed ID: 27609113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
    Grupper M; Kuti JL; Swank ML; Maggio L; Hughes BL; Nicolau DP
    J Clin Pharmacol; 2017 Jun; 57(6):712-719. PubMed ID: 27925657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue pharmacokinetics of cefazolin in patients with lower limb infections.
    Bhalodi AA; Housman ST; Shepard A; Nugent J; Nicolau DP
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5679-83. PubMed ID: 24041887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
    Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
    J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic model for cefazolin distribution during total hip arthroplasty in dogs.
    Marcellin-Little DJ; Papich MG; Richardson DC; DeYoung DJ
    Am J Vet Res; 1996 May; 57(5):720-3. PubMed ID: 8723889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic disposition of cefazolin in serum and tissue during canine total hip replacement.
    Richardson DC; Aucoin DP; DeYoung DJ; Tyczkowska KL; DeYoung BA
    Vet Surg; 1992; 21(1):1-4. PubMed ID: 1580051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to determine the feasibility of continuous cefazolin infusion.
    Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
    Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
    Swank ML; Wing DA; Nicolau DP; McNulty JA
    Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.